share_log

G1 Therapeutics shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.

Benzinga ·  Feb 25, 2021 05:16
G1 Therapeutics shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment